Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126154702 | 12615470 | 2 | F | 20160919 | 20160802 | 20160927 | EXP | JP-AMGEN-JPNSP2016095867 | AMGEN | 0.00 | Y | 0.00000 | 20160927 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126154702 | 12615470 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG EVERY OTHER WEEK | U | 103795 | 25 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||
| 126154702 | 12615470 | 2 | SS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | 2M CAPSULES UNKNOWN DOSE AND FORMULATION | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126154702 | 12615470 | 1 | Product used for unknown indication |
| 126154702 | 12615470 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126154702 | 12615470 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126154702 | 12615470 | Inappropriate schedule of drug administration | |
| 126154702 | 12615470 | Lymphoproliferative disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |